Characteristics of cerebrovascular accidents at time of diagnosis in a series of 98 patients with giant cell arteritis

被引:35
|
作者
Zenone, Thierry [1 ]
Puget, Marie [1 ]
机构
[1] Ctr Hosp, Dept Internal Med, F-26953 Valence 9, France
关键词
Giant cell arteritis; Stroke; Vasculitis; CRANIAL ISCHEMIC COMPLICATIONS; OF-THE-LITERATURE; POLYMYALGIA-RHEUMATICA; POSTERIOR CIRCULATION; TEMPORAL ARTERITIS; STEROID-THERAPY; CAROTID-ARTERY; RISK-FACTORS; VISUAL-LOSS; STROKE;
D O I
10.1007/s00296-013-2814-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of this study was to determine the characteristics of cerebrovascular accidents at time of diagnosis in patients with giant cell arteritis. Retrospective data were collected from 98 patients at a single hospital with giant cell arteritis (according to the American College of Rheumatology classification criteria) diagnosed between October 1999 and January 2012. Cerebrovascular accident was found at initial presentation in 6 patients (6.1 %, 95 % CIs 2.3-12.9). Most of them had other symptoms of giant cell arteritis when the disease began. Signs reflecting the involvement of vertebro-basilar territory were present in 3 cases. No other case of cerebrovascular accident was described during the follow-up of patient; particularly no case of cerebrovascular accident occurred once corticosteroid therapy for the treatment of giant cell arteritis had been initiated. No differences in the epidemiologic, clinical and laboratory features at the time of diagnosis between patients who had cerebrovascular accidents and the rest of the giant cell arteritis patients were observed. Prognosis was good in our survey. However, there was no case of bilateral vertebral artery occlusion, a condition associated with poor prognosis. The present study confirms that cerebrovascular accidents may be the initial manifestation of giant cell arteritis, an argument in favor of a direct effect of the vasculitis in the development of cerebrovascular accidents rather than a complication of the corticosteroid therapy. The diagnosis of giant cell arteritis should always be considered in an elderly patient with stroke and an unexplained elevation of inflammatory biomarkers.
引用
收藏
页码:3017 / 3023
页数:7
相关论文
共 50 条
  • [21] The Diagnosis and Treatment of Giant Cell Arteritis
    Ness, Thomas
    Bley, Thorsten A.
    Schmidt, Wolfgang A.
    Lamprecht, Peter
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2013, 110 (21): : 376 - U27
  • [22] Giant cell arteritis: diagnosis and management
    Bhatti, M. Tariq
    Tabandeh, Homayoun
    CURRENT OPINION IN OPHTHALMOLOGY, 2001, 12 (06) : 394 - 400
  • [23] DIAGNOSIS OF GIANT-CELL ARTERITIS
    DUNKER, PJ
    EBEL, J
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1982, 107 (25) : 987 - 988
  • [24] Advances in the diagnosis of giant cell arteritis
    Ing, Edsel
    Pagnoux, Christian
    Torun, Nurhan
    CURRENT OPINION IN OPHTHALMOLOGY, 2019, 30 (06) : 407 - 411
  • [25] ULTRASONOGRAPHY IN THE DIAGNOSIS OF GIANT CELL ARTERITIS
    Jese, R.
    Rotar, Z.
    Tomsic, M.
    Hocevar, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 676 - 676
  • [26] Comment on: Diagnosis of giant cell arteritis
    Ing, Edsel B.
    RHEUMATOLOGY, 2020, 59 (11) : E118 - E118
  • [27] Ultrasonography in the Diagnosis of Giant Cell Arteritis
    Jese, Rok
    Rotar, Ziga
    Tomsic, Matija
    Hocevar, Alojzija
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [28] Giant cell arteritis: Diagnosis and management
    Kachroo, A
    Tello, C
    Bais, R
    Panush, RS
    BULLETIN ON THE RHEUMATIC DISEASES, 1996, 45 (05) : 2 - 5
  • [29] Diagnosis and Treatment of Giant Cell Arteritis
    Fabrizio Cantini
    Laura Niccoli
    Carlotta Nannini
    Michele Bertoni
    Carlo Salvarani
    Drugs & Aging, 2008, 25 : 281 - 297
  • [30] Diagnosis and management of giant cell arteritis
    Barraclough, Kevin
    Mallen, Christian D.
    Helliwell, Toby
    Hider, Samantha L.
    Dasgupta, Bhaskar
    BRITISH JOURNAL OF GENERAL PRACTICE, 2012, 62 (599): : 329 - 330